Filter

31 - 40 of 156 Results

  • Poll Finds 62% of Americans Approve of the Supreme Court’s Decision to Continue Allowing ACA Health Insurance Subsidies in All States, While 32% Disapprove

    News Release

    Public’s View of the Health Care Law Remains Nearly Evenly Divided Immediately Following King v. Burwell Ruling Nearly Eight in 10 Americans Expect More Major Battles about the ACA in the Future Just over six in 10 Americans (62%) say they approve of the U.S. Supreme Court’s decision last week to continue allowing low- and moderate-income people in all states to be eligible for government subsidies to buy health plans through Affordable Care Act (ACA)…

  • Kaiser Poll: Early Reaction to Supreme Court Decision on ACA

    Perspective

    Following last week's Supreme Court's decision upholding the heart of the Affordable Care Act (ACA), a majority of Americans (56 percent) now say they would like to see the law's detractors stop their efforts to block its implementation and move on to other national problems. In the first of two polls to be released this month looking at opinion on the ACA in the wake of the Court's decision, Democrats overwhelmingly say opponents should move…

  • What a Break in the Obamacare Battles Could Bring

    News Release

    Following the Supreme Court’s King v. Burwell decision, the Affordable Care Act could use a break from the intense political heat, though it may not get a long one as the 2016 election season heats up and presidential candidates play to their bases on health care, writes Drew Altman in his latest column for The Wall Street Journal’s Think Tank. All previous columns by Drew Altman are available.

  • Facing the Fallout From a King v. Burwell Ruling

    News Release

    With a Supreme Court decision on King v. Burwell looming, Drew Altman's latest column for The Wall Street Journal’s Think Tank plays out the politics of a ruling for the two major parties. All previous columns by Drew Altman are available.

  • Web Briefing for Media – The Supreme Court, Birth Control, and Religious Freedom: Implications of Zubik v. Burwell

    Event Date:
    Event

    On March 23, the U.S. Supreme Court will hear Zubik v. Burwell, legal challenges brought by nonprofit corporations challenging the Affordable Care Act's contraceptive coverage requirement. The 2014 Hobby Lobby decision established that certain firms with religious beliefs should be relieved of the requirement of paying for contraceptive coverage. In this case, religious nonprofits are objecting to the regulations that the Obama Administration has developed to accommodate their religious objections to birth control, claiming it…

  • What Happens to Medicaid Drug Policy if the ACA is Overturned?

    Issue Brief

    The repeal of the ACA could mean loss of Medicaid coverage for up to 15 million that were enrolled in the ACA Medicaid expansion group prior to the COVID-19 pandemic; however, repeal could also mean significant changes to Medicaid prescription drug policy with implications for state and federal spending for prescription drugs for non-expansion Medicaid enrollees.

  • Explaining Armstrong v. Exceptional Child Center: The Supreme Court Considers Private Enforcement of the Medicaid Act

    Issue Brief

    On January 20, 2015, the United States Supreme Court will hear oral argument in Armstrong v. Exceptional Child Center, a case that raises the issue of whether Medicaid providers can challenge a state law in federal court on the basis that it violates the federal Medicaid Act and therefore is preempted by the Supremacy Clause of the U.S. Constitution. This issue brief examines the major questions raised by the Armstrong case, explains the parties’ legal…

  • What a Break in the Obamacare Battles Could Bring

    From Drew Altman

    Following the Supreme Court’s King v. Burwell decision, the Affordable Care Act could use a break from the intense political heat, though it may not get a long one as the 2016 election season heats up and presidential candidates play to their bases on health care, writes Drew Altman in his latest column for The Wall Street Journal’s Think Tank.